An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Figure 1
Micro-organisms as initiating events in…
Figure 1
Micro-organisms as initiating events in the pathogenesis of MGUS and MM, and interest…
Figure 1
Micro-organisms as initiating events in the pathogenesis of MGUS and MM, and interest for treatment. MM is always preceded by a MGUS stage, considered benign since only a fraction of MGUS eventually progress toward to overt MM. Although MGUS is most often asymptomatic, patients may present with renal, neurological or skin symptoms of various severity (for instance, monoclonal gammopathies of renal significance (MGRS)) (–8). Associations between MGUS and autoimmune disorders, infection and recently, gut microbiota, are established (, , , , –22). Importantly, several groups demonstrated that monoclonal Ig from MGUS and MM patients specifically target either a self-antigen (including myelin-associated glycoprotein (MAG), glucosylsphingosine (GlcSph, in 13-15% MGUS/MM cases), other gangliosides, different membrane components) or an antigen from an infectious pathogen (including HCV, HBV, HIV, EBV, other Herpesviruses, Helicobacter pylori, or Enteroviruses, in 60% MGUS and 33% MM). That subsets of monoclonal Igs target antigens of the microbiota remains to be proven. Knowing the target of a patient’s monoclonal Ig is essential, for it allows to identify the likely initiating event of the disease, and to propose target antigen reduction therapy to patients. The efficacy of this new therapeutic approach is proven for GlcSph-, HIV- and HCV-initiated monoclonal gammopathies (, , Rodríguez–García et al.), and deserves to be tested for MGUS and MM initiated by other treatable microorganisms.
Editorial on the Research Topic The Role of Microorganisms in Multiple Myeloma
References
Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. . International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma. Lancet Oncol (2014) 15:e538–48. doi: 10.1016/S1470-2045(14)70442-5
-
DOI
-
PubMed
Dhodapkar MV. MGUS to Myeloma: A Mysterious Gammopathy of Underexplored Significance. Blood (2016) 128:2599–606. doi: 10.1182/blood-2016-09-692954
-
DOI
-
PMC
-
PubMed
Nair S, Branagan AR, Liu J, Boddupalli CS, Mistry PK, Dhodapkar MV. Clonal Immunoglobulin Against Lysolipids in the Origin of Myeloma. N Engl J Med (2016) 374:555–61. doi: 10.1056/NEJMoa1508808
-
DOI
-
PMC
-
PubMed
Nair S, Sng J, Boddupalli CS, Seckinger A, Chesi M, Fulciniti M, et al. . Antigen-Mediated Regulation in Monoclonal Gammopathies and Myeloma. JCI Insight (2018) 3:e98259. doi: 10.1172/jci.insight.98259
-
DOI
-
PMC
-
PubMed
Mameli G, Fozza C, Niegowska M, Corda G, Ruda MF, Barraqueddu F, et al. . Epstein–Barr Virus Infection Is Associated to Patients With Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance. Leuk Lymphoma (2017) 58:466–9. doi: 10.1080/10428194.2016.1190976
-
DOI
-
PubMed